Searching for a way to live to the end: Decision-making process in patients considering participation in cancer phase I clinical trials

Oncology Nursing Forum

Volumn 37, Issue 2, 2010, Pages

  Kohara, Izumi ^a   Inoue, Tomoko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ASIAN; ATTITUDE TO DEATH; ATTITUDE TO HEALTH; DECISION MAKING; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGED; NEOPLASM; NURSING; NURSING METHODOLOGY RESEARCH; ONCOLOGY NURSING; PATIENT PARTICIPATION; PHASE 1 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT; TREATMENT REFUSAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO DEATH; ATTITUDE TO HEALTH; CLINICAL TRIALS, PHASE I AS TOPIC; DECISION MAKING; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; NURSING METHODOLOGY RESEARCH; ONCOLOGIC NURSING; PATIENT PARTICIPATION; TREATMENT REFUSAL;

EID: 77953050455     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/10.ONF.E124-E132     Document Type: Article

References (26)

1. Aaronson, N.K., Visser-Pol, E., Leenhouts, G.H., Muller, M.J., Astrid, C.M., Schot, V.D., Dubbelman, R. (1996). Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. Journal of Clinical Oncology, 14, 984-996. (Pubitemid 26085547)
2. Agrawal, M., & Danis, M. (2002). End-of-life care for terminally ill participants in clinical research. Journal of Palliative Medicine, 5, 729-737. doi: 10.1089/109662102320880552 (Pubitemid 35283434)
3. Agrawal, M., & Emanuel, E.J. (2003). Ethics of phase I oncology studies: Reexamining the arguments and data. JAMA, 290, 1075-1082. doi: 10.1001/jama.290.8.1075 (Pubitemid 37430449)
4. Agrawal, M., Grady, C.L., Fairclough, D.J., Meropol, N., Maynard, K.J., & Emanuel, E.J. (2006). Patients' decision-making process regarding participation in phase I oncology research. Journal of Clinical Oncology, 24, 4479-4484. doi: 10.1200/JCO.2006.06.0269 (Pubitemid 46630987)
5. Appelbaum, P.S., & Grisso, T. (1988). Assessment of patients' capacities to consent to treatment. New England Journal of Medicine, 319, 1635-1638. (Pubitemid 19015237)
6. Bachelot, T., Ray-Coquard, I., Catimel, G., Ardiet, C., Guastalla, J.P., Dumortier, A., Clavel, M. (2000). Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials. Annals of Oncology, 11, 151-156. (Pubitemid 30148727)
7. Barrett, R. (2005). Quality of informed consent: Measuring understanding among participants in oncology clinical trials. Oncology Nursing Forum, 32, 751-755. doi: 10.1188/05.ONF.751-755
8. Cheng, J.D., Hitt, J., Koczwara, B., Schulman, K.A., Burnett, C.B., Gaskin, D.J., Meropol, N.J. (2000). Impact of quality of life on patient expectations regarding phase I clinical trials. Journal of Clinical Oncology, 18, 421-428. (Pubitemid 30056433)
9. Cox, K. (2000). Enhancing cancer clinical trial management: Recommendations from a qualitative study of trial participants' experiences. Psycho-Oncology, 9, 314-322.
10. Daugherty, C., Ratain, M.J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., & Siegler, M. (1995). Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology, 13, 1062-1072.
11. Flory, J., & Emanuel, E. (2004). Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA, 292, 1593-1601. doi: 10.1001/jama.292.13.1593 (Pubitemid 39314966)
12. Han, C., Braybrooke, J., Deplanque, G., Taylor, M., Mackintosh, D., Kaur, K., Talbot, D.C. (2003). Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs versus new noncytotoxic agents. British Journal of Cancer, 89, 1166-1171. doi: 10.1038/sj.bjc.6601218 (Pubitemid 37363397)
13. Horng, S., Emanuel, E.J., Wilfond, B., Rackoff, J., Martz, K., & Grady, C. (2002). Descriptions of benefits and risks in consent forms for phase 1 oncology trials. New England Journal of Medicine, 347, 2134-2140. doi: 10.1056/NEJMsa021182 (Pubitemid 36015126)
14. Horstmann, E., McCabe, M.S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, T., Grady, C. (2005). Risks and benefits of phase I oncology trials, 1991 through 2002. New England Journal of Medicine, 352, 895-904. doi: 10.1056/NEJMsa042220 (Pubitemid 40300298)
15. Itoh, K., Sasaki, Y., Fujii, H., Ohtsu, T., Wakita, H., Igarashi, T., & Abe, K. (1997). Patients in phase I trials of anticancer agents in Japan: Motivation, comprehension and expectations. British Journal of Cancer, 76, 107-113. (Pubitemid 27250084)
16. Joffe, S., Cook, E.F., Cleary, P.D., Clark, J.W., & Weeks, J.C. (2001). Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet, 358(9295), 1772-1777. doi: 10.1016/S0140-6736(01)06805-2 (Pubitemid 33153003)
17. Lengacher, C.A., Gonzalez, L., Giuliano, R., Bennett, M.P., Cox, C.E., & Reintgen, D.S. (2001). The process of clinical trials: A model for successful clinical trial participation. Oncology Nursing Forum, 28, 1115-1120.
18. Madsen, S.M., Holm, S., & Riis, P. (2007). Participating in a cancer clinical trial? The balancing of options in the loneliness of autonomy: A grounded theory interview study. Acta Oncologica, 46, 49-59.
19. Meropol, N.J., Weinfurt, K.P., Burnett, C.B., Balshem, A., Benson, A.B., Castel, L., Schulman, K.A. (2003). Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. Journal of Clinical Oncology, 21, 2589-2596. doi: 10.1200/JCO.2003.10.072 (Pubitemid 46606342)
20. Moore, S. (2001). A need to try everything: Patient participation in phase I trials. Journal of Advanced Nursing, 33, 738-747. (Pubitemid 33603217)
21. Nurgat, Z., Craig, W., Campbell, N., Bissett, J., Cassidy, J., & Nicolson, M. (2005). Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. British Journal of Cancer, 92, 1001-1005. doi: 10.1038/sj.bjc.6602423 (Pubitemid 40546660)
22. Pierce, P.F., & Hicks, F.D. (2001). Patient decision-making behavior: An emerging paradigm for nursing science. Nursing Research, 50, 267-274. (Pubitemid 33603817)
23. Schaefer, K.M., Ladd, E., Gergits, M.A., & Gyauch, L. (2001). Backing and forthing: The process of decision making by women considering participation in a breast cancer prevention trial. Oncology Nursing Forum, 28, 703-709.
24. Schutta, K.M., & Burnett, C.B. (2000). Factors that influence a patient's decision to participate in a phase I cancer clinical trial. Oncology Nursing Forum, 27, 1435-1438.
25. Strauss, A.L., & Corbin, J.M. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.
26. Yoder, L.H., O'Rourke, T.J., Etnyre, A., Spears, D.T., & Brown, T.D. (1997). Expectations and experiences of patients with cancer participating in phase I clinical trials. Oncology Nursing Forum, 24, 891-896.